Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 631.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 106.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -675.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 33.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -344.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -37,361.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 3,557.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 622.00 |
| 10 | Takeda Pharmaceutical | 171,987.39 | -6.60 Bn | 4.39 Bn | -672.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -672.00 |
| Dec 31, 2025 | 367.00 |
| Sep 30, 2025 | -15,043.00 |
| Jun 30, 2025 | -644.00 |
| Mar 31, 2025 | -193.00 |
| Dec 31, 2024 | -519.00 |
| Sep 30, 2024 | -132.00 |
| Jun 30, 2024 | -988.00 |
| Mar 31, 2024 | -350.00 |
| Dec 31, 2023 | -611.00 |
| Sep 30, 2023 | -16,512.00 |
| Jun 30, 2023 | -333.00 |
| Mar 31, 2023 | -489.00 |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | -6.56 Mn |
| Mar 31, 2022 | -3.88 Bn |
| Dec 31, 2021 | -349.00 |
| Jun 30, 2021 | 141.00 |
| Mar 31, 2021 | -525.00 |
| Dec 31, 2020 | -110.00 |